Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.
Kentaro ChinoTsuneo KondoRyota SakaiShuntaro SaitoYusuke OkadaAkiko ShibataTakahiko KurasawaAyumi OkuyamaHirofumi TakeiKoichi AmanoPublished in: International journal of rheumatic diseases (2019)
TCZ monotherapy is well tolerated and can lead to remission in most patients with PMR in the absence of glucocorticoids.